Thomas Haughey

Thomas Haughey is a declared insider of ANI Pharmaceuticals Inc (board member), with filings sourced from SEC (Form 4). In total, 8 filings cover trades dated from 6 December 2021 to 8 June 2026.

In open-market terms, that means 1 purchase worth €87k on one side and 2 sales worth €1.4M on the other. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants. In 2026 alone, the filings show no purchases and 1 sale.

The latest filing, published on 10 June 2026, reports a share grant in ANI Pharmaceuticals Inc. The latest purchase dates back some time: it was published 1,776 days ago, on 7 December 2021. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.